Bernstein Liebhard LLP is a leader in litigating cases involving dangerous drugs, defective medical devices and consumer products. Our user-friendly website is an information and resource center for individuals and their families seeking assistance with their litigation needs.

Featured Cases

Latest News More News
The National Law Journal Names Bernstein Liebhard LLP to Its “2016 Elite Trial Lawyers” List
October 20, 2016 Bernstein Liebhard LLP is honored to announce that the firm has been recognized by The National Law Journal as one of a select group of “America’s Elite Trial Lawyers” for the third […] ...
Zofran Manufacturer Asks Federal Court to Nix Fraud Claims in Birth Defects MDL
GlaxoSmithKline has asked a federal court to dismiss fraud claims put forth in hundreds of Zofran birth defects lawsuits now pending in a multidistrict litigation underway in the U.S. District Court, District of Massachusetts. According […] ...
Levaquin Attorneys at Bernstein Liebhard LLP File Aortic Dissection Lawsuit
The Levaquin attorneys at Bernstein Liebhard LLP continue to actively pursue legal claims involving the side effects allegedly associated with the use of fluoroquinolone antibiotics. The Firm’s most recent case was filed in late September, […] ...
Seven Bernstein Liebhard Attorneys Recognized as 2016 Super Lawyers and Rising Stars
October 7, 2016 Bernstein Liebhard LLP is pleased to announce that seven of the Firm’s attorneys have been named by Super Lawyers to be among the top lawyers in New York State.  Super Lawyers ranks […] ...

A Nationwide Law Practice

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products.  The Firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country for thirteen years.

Our trial attorneys have handled hundreds of cases on behalf of injured consumers and shareholders, recovering over $3.5 billion for our clients.  We have achieved this level of success for our clients by bringing together a unique array of talent.  Our ranks include former attorneys with prominent national law firms, former prosecutors, former regulatory attorneys, former U.S. Circuit Court of Appeals law clerks, former U.S. district court law clerks, in-house investigators, and other expert staff.  In short, when we face off against large corporations, their attorneys and their insurance companies know that we are experienced, trial ready and go the extra mile to bring home wins for our clients.  And our clients rest assured that their rights are being protected by highly experienced counsel.

Among other claims currently being investigated and evaluated by the Firm, which involve a widely array of dangerous drugs, medical devices and consumer products on the U.S. market, our attorneys are actively pursuing testosterone lawsuit claims on behalf of individuals who may have been injured by one of several “Low T” treatment therapies.  These hormone-raising medications may be associated with the risk for heart attacks, strokes and other serious cardiovascular side effects.

Bernstein Liebhard LLP is also evaluating potential legal claims involving serious kidney injuries and proton pump inhibitors, including Nexium, Prilosec and Prevacid. Recent studies have linked the long-term use of these popular heartburn drugs to a number of serious kidney side effects, including kidney failure, chronic kidney disease, acute kidney injury and nephritis. You may be entitled to compensation for medical bills, lost wages, pain and suffering, and more if you suffered kidney damage that could be related to a proton pump inhibitor. Bernstein Liebhard LLP offers free legal reviews to those harmed by prescription and over-the-counter drugs, including Nexium, Prevacid and Prilosec. If you would like to discuss a case with our legal staff, please visit our Nexium Lawsuit Center.